Circle with the words ‘reduce your carbon Rx footprint’ around the outside and an image of a footprint in the centre

Product menu

  • Prescribing Information links at bottom of page
Image of hands holding the World with a green background

Lowered prices, low carbon - prescribe Accuhaler for appropriate patients with asthma

List price reductions for one SABA and three ICS packs from 1st August 2022

Flixotide (fluticasone propionate) Accuhaler Indication1

Flixotide Accuhaler offers preventative treatment for asthma.

For Adults: Prophylactic management in mild asthma for patients requiring intermittent symptomatic bronchodilator asthma medication on a regular daily basis; prophylactic management in moderate asthma for patients with unstable or worsening asthma despite prophylactic therapy or bronchodilator alone; prophylactic management in severe asthma for patients with severe chronic asthma and those who are dependent on systemic corticosteroids for adequate control of symptoms.

For children: Any child who requires prophylactic medication for asthma, including patients not controlled on currently available prophylactic medication.

Ventolin (salbutamol) Accuhaler Indication2

Ventolin Accuhaler is indicated in adults, adolescents and children aged 4 to 11 years. Ventolin Accuhaler can be used in the management of asthma, bronchospasm and/or reversible airways obstruction.

Be proactive - control asthma and reduce carbon

Picture of a Flixotide (fluticasone propionate) 100mcg Accuhaler device

Flixotide (fluticasone propionate) Accuhaler

Low carbon and now cheaper than the most commonly prescribed MDI and DPI ICS brands3

Click to compare prices

Picture of a Ventolin (salbutamol) Accuhaler device

Ventolin (salbutamol) Accuhaler

Ventolin Accuhaler list price reduced by 45% from 1st August 2022, making it more affordable for patients who need a SABA - choose Accuhaler, stay with Ventolin, reduce carbon

Click to compare prices

Green arrow pointing downwards with the outline of two footprints inside it

Carbon footprints

Compare the carbon footprints of Ventolin and Flixotide Accuhalers with commonly prescribed ICS and SABA inhalers

Compare now

Prescribing Information Links

Flixotide Prescribing Information (PDF)

Flixotide SmPC

Ventolin Prescribing Information (PDF)

Ventolin SmPC

References

  1. Flixotide Accuhaler SPC
  2. Ventolin Accuhaler SPC
  3. IQVIA prescribed data prescribed volume MAT April 2022

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441

© 2021 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.

July 2022 | PM-GB-FLP-WCNT-220001 (V1.0)